Three-year data from the XIENCE V INDIA study: safety and efficacy of XIENCE V in 1000 real world Indian patients. [electronic resource]
Producer: 20151016Description: 302-8 p. digitalISSN:- 2213-3763
- Antineoplastic Agents
- Coronary Angiography
- Coronary Artery Disease -- diagnostic imaging
- Drug-Eluting Stents
- Everolimus
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents -- pharmacology
- Incidence
- India -- epidemiology
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction -- diagnostic imaging
- Percutaneous Coronary Intervention -- adverse effects
- Postoperative Complications -- diagnostic imaging
- Prognosis
- Prospective Studies
- Prosthesis Design
- Risk Assessment
- Risk Factors
- Sirolimus -- analogs & derivatives
- Survival Rate -- trends
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.